LWBA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mesoblast Ltd

Watchlist Manager

Watchlist

Price: 3.58 EUR 0.56% Market Closed

Market Cap: €582.6m

M	Mesoblast Ltd F:LWBA	AU
	HLS Therapeutics Inc F:74D	CA
C	Cincinnati Financial Corp SWB:CCJ	US
	Nikon Corp F:NKN	JP
	Thales SA F:CSF0	FR
A	Arcadis NV XMUN:HIJ2	NL
A	AXA SA XMUN:AXA	FR
	Electricite de Strasbourg SA PAR:ELEC	FR
D	Dynex Capital Inc F:DYT1	US
	JPMorgan Chase & Co XETRA:CMC	US
W	Wharf Holdings Ltd OTC:WARFY	HK
	Thumzup Media Corp NASDAQ:DTCX	US
	EML Payments Ltd ASX:EML	AU
	AXA SA PAR:CS	FR
F	Fresenius Medical Care AG & Co KGaA XBER:FME	DE
A	Aalberts NV OTC:AALBF	NL
	Persol Holdings Co Ltd OTC:TEMPF	JP
	Nickel Mines Ltd ASX:NIC	AU
S	Spearmint Resources Inc CNSX:SPMT	CA
	Sandvik AB OTC:SDVKF	SE

Profitability Summary

Mesoblast Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Negative 3Y Average Gross Margin

-50%

Gross Margin is Increasing

-284% > 58%

Negative Operating Margin

-112%

Negative 3Y Average Operating Margin

-786%

Operating Margin is Increasing

-805% > -112%

Negative Net Margin

-144%

Negative 3Y Average Net Margin

-1 020%

Net Margin is Increasing

-1 081% > -144%

Negative Free Cash Flow Margin

-93%

Negative 3Y Average Free Cash Flow Margin

-601%

Free Cash Flow Margin is Increasing

-672% > -93%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC